nach oben

Die Kardiologie

Erschienen in:

01.06.2015 | Übersichten

Schokolade, Alkohol und Kaffee

Lifestyle und kardiovaskuläre Erkrankungen

verfasst von: PD Dr. T. Walter, J. Grüttner, M. Borggrefe, S. Swoboda

Erschienen in: Die Kardiologie | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Zusammenfassung

Schokolade, Alkohol und Kaffee sind Produkte, die aus dem täglichen Leben vieler Menschen nicht wegzudenken sind. Häufig werden diesen negative gesundheitliche Wirkungen nachgesagt, während neuere Untersuchungen in den letzten Jahren auch positive Effekte dieser Genussmittel im Hinblick auf kardiovaskuläre Erkrankungen nachweisen konnten. Als Ursache hierfür werden unter anderem Polyphenole verantwortlich gemacht, die z. B. in Kakao und Rotwein enthalten sind und antioxidative Wirkungen haben. Obwohl es unstrittig ist, dass übermäßiger Alkoholkonsum gesundheitsschädlich ist, gibt es auch Hinweise auf kardioprotektive Wirkungen. Kaffee, das beliebteste Getränk der Deutschen, enthält neben Polyphenolen noch zahlreiche weitere Inhaltsstoffe. Am besten untersucht ist das Koffein, das ebenso wie Alkohol in den letzten Jahren Gegenstand zahlreicher Untersuchungen war. Diese Übersichtsarbeit soll einen Überblick über die vorhandene Datenlage in Bezug auf die Wirkung von Schokolade, Alkohol und Kaffee auf kardiovaskuläre Erkrankungen geben.

http://de.statista.com/statistik/daten/studie/20040/umfrage/jaehrlicher-schokoladenkonsum-pro-kopf-in-ausgewaehlten-laender. Zugegriffen: 04. Nov. 2014

Deutsches Weininstitut. Deutscher Wein Statistik 2013/2014. http://www.deutscheweine.de. Zugegriffen: 04. Nov. 2014

http://de.statista.com/statistik/daten/studie/199898/umfrage/konsum-von-kaffee-in-europa. Zugegriffen: 04. Nov. 2014

http://www.who.int/mediacentre/factsheets/fs317/en. Zugegriffen: 04. Nov. 2014

Manach C, Scalbert A, Morand C et al (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79(5):727–747 PubMed

Worm N, Belz GG, Stein-Hammer C (2013) Moderater Weingenuss und Prävention der koronaren Herzkrankheit. Dtsch Med Wochenschr 138(51–52):2653–2657

Bohn SK, Ward NC, Hodgson JM, Croft KD (2012) Effects of tea and coffee on cardiovascular disease risk. Food Funct 3(6):575–591 PubMedCrossRef

Tome-Carneiro J, Gonzalvez M, Larrosa M et al (2013) Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci 1290:37–51 PubMedCrossRef

Cano-Marquina A, Tarin JJ, Cano A (2013) The impact of coffee on health. Maturitas 75(1):7–21 PubMedCrossRef

10.

Corti R, Flammer AJ, Hollenberg NK, Luscher TF (2009) Cocoa and cardiovascular health. Circulation 119(10):1433–1441 PubMedCrossRef

11.

Cordova AC, Jackson LS, Berke-Schlessel DW, Sumpio BE (2005) The cardiovascular protective effect of red wine. J Am Coll Surg 200(3):428–439 PubMedCrossRef

12.

Corder R (2008) Red wine, chocolate and vascular health: developing the evidence base. Heart 94(7):821–823 PubMedCrossRef

13.

Pearson DA, Holt RR, Rein D et al (2005) Flavanols and platelet reactivity. Clin Dev Immunol 12(1):1–9 PubMedCentralPubMedCrossRef

14.

Flammer AJ, Sudano I, Wolfrum M et al (2012) Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur Heart J 33(17):2172–2180 PubMedCrossRef

15.

Flammer AJ, Hermann F, Sudano I et al (2007) Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 116(21):2376–2382 PubMedCrossRef

16.

Shiina Y, Funabashi N, Lee K et al (2009) Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol 131(3):424–429 PubMedCrossRef

17.

Pereira T, Maldonado J, Laranjeiro M et al (2014) Central arterial hemodynamic effects of dark chocolate ingestion in young healthy people: a randomized and controlled trial. Cardiol Res Pract. doi:10.1155/2014/945951

18.

Grassi D, Necozione S, Lippi C et al (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46(2):398–405 PubMedCrossRef

19.

Loffredo L, Perri L, Catasca E et al (2014) Dark chocolate acutely improves walking autonomy in patients with peripheral artery disease. J Am Heart Assoc 3(4):e001072 PubMedCentralPubMedCrossRef

20.

Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8(11):1227–1234 PubMedCrossRef

21.

Innes AJ, Kennedy G, McLaren M et al (2003) Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets 14(5):325–327 PubMedCrossRef

22.

Hamed MS, Gambert S, Bliden KP et al (2008) Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med J 101(12):1203–1208 PubMedCrossRef

23.

Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159–2219 PubMedCrossRef

24.

Desch S, Schmidt J, Kobler D et al (2010) Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 23(1):97–103 PubMedCrossRef

25.

Buijsse B, Feskens EJ, Kok FJ, Kromhout D (2006) Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med 166(4):411–417 PubMed

26.

Desch S, Kobler D, Schmidt J et al (2010) Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens 23(6):694–700 PubMedCrossRef

27.

Taubert D, Berkels R, Roesen R, Klaus W (2003) Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 290(8):1029–1030 PubMedCrossRef

28.

Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21(12):2281–2286 PubMedCrossRef

29.

Engler MB, Engler MM, Chen CY et al (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23(3):197–204 PubMedCrossRef

30.

Taubert D, Roesen R, Schomig E (2007) Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 167(7):626–634 PubMedCrossRef

31.

Stamler R (1991) Implications of the INTERSALT study. Hypertension 17(1 Suppl):I16–I20 PubMedCrossRef

32.

Janszky I, Mukamal KJ, Ljung R et al (2009) Chocolate consumption and mortality following a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med 266(3):248–257 PubMedCrossRef

33.

Buitrago-Lopez A, Sanderson J, Johnson L et al (2011) Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 343:d4488. doi:10.1136/bmj.d4488 PubMedCentralPubMedCrossRef

34.

Petrone AB, Gaziano JM, Djousse L (2014) Chocolate consumption and risk of heart failure in the Physicians‘ Health Study. Eur J Heart Fail 16(12):1372–1376 PubMedCrossRef

35.

Monagas M, Khan N, Andres-Lacueva C et al (2009) Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr 90(5):1144–1150 PubMedCrossRef

36.

Arranz S, Valderas-Martinez P, Chiva-Blanch G et al (2013) Cardioprotective effects of cocoa: clinical evidence from randomized clinical intervention trials in humans. Mol Nutr Food Res 57(6):936–947 PubMedCrossRef

37.

Messerli FH (2012) Chocolate consumption, cognitive function, and Nobel laureates. N Engl J Med 367(16):1562–1564 PubMedCrossRef

38.

Corder R, Mullen W, Khan NQ et al (2006) Oenology: red wine procyanidins and vascular health. Nature 444(7119):566 PubMedCrossRef

39.

Hashimoto M, Kim S, Eto M et al (2001) Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 88(12):1457–1460, A9 PubMedCrossRef

40.

Shimada K, Watanabe H, Hosoda K et al (1999) Effect of red wine on coronary flow-velocity reserve. Lancet 354(9183):1002 PubMedCrossRef

41.

Hozumi T, Sugioka K, Shimada K et al (2006) Beneficial effect of short term intake of red wine polyphenols on coronary microcirculation in patients with coronary artery disease. Heart 92(5):681–682 PubMedCentralPubMedCrossRef

42.

Estruch R, Sacanella E, Badia E et al (2004) Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175(1):117–123 PubMedCrossRef

43.

Chiva-Blanch G, Urpi-Sarda M, Llorach R et al (2012) Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial. Am J Clin Nutr 95(2):326–334 PubMedCrossRef

44.

Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, Estruch R (2013) Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol 48(3):270–277 PubMedCrossRef

45.

Droste DW, Iliescu C, Vaillant M et al (2013) A daily glass of red wine and lifestyle changes do not affect arterial blood pressure and heart rate in patients with carotid arteriosclerosis after 4 and 20 weeks. Cerebrovasc Dis Extra 3(1):121–129 PubMedCentralPubMedCrossRef

46.

Krenz M, Korthuis RJ (2012) Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol 52(1):93–104 PubMedCentralPubMedCrossRef

47.

St Leger AS, Cochrane AL, Moore F (1979) Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1(8124):1017–1020

48.

Renaud S, Lorgeril M de (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339(8808):1523–1526 PubMedCrossRef

49.

Gronbaek M, Deis A, Sorensen TI et al (1995) Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 310(6988):1165–1169 PubMedCentralPubMedCrossRef

50.

Lorgeril M de, Salen P, Martin JL et al (2002) Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation 106(12):1465–1469 PubMedCrossRef

51.

Corrao G, Rubbiati L, Bagnardi V et al (2000) Alcohol and coronary heart disease: a meta-analysis. Addiction 95(10):1505–1523 PubMedCrossRef

52.

Ronksley PE, Brien SE, Turner BJ et al (2011) Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 342:d671. doi:10.1136/bmj.d671 PubMedCentralPubMedCrossRef

53.

Di CA, Costanzo S, Bagnardi V et al (2006) Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166(22):2437–2445 CrossRef

54.

Hvidtfeldt UA, Tolstrup JS, Jakobsen MU et al (2010) Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation 121(14):1589–1597 PubMedCentralPubMedCrossRef

55.

Mukamal KJ, Chung H, Jenny NS et al (2005) Alcohol use and risk of ischemic stroke among older adults: the cardiovascular health study. Stroke 36(9):1830–1834 PubMedCrossRef

56.

Mukamal KJ, Chiuve SE, Rimm EB (2006) Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med 166(19):2145–2150 PubMedCrossRef

57.

Zairis MN, Ambrose JA, Lyras AG et al (2004) C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study. Heart 90(4):419–424 PubMedCentralPubMedCrossRef

58.

Juonala M, Viikari JS, Kahonen M et al (2009) Alcohol consumption is directly associated with carotid intima-media thickness in Finnish young adults: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 204(2):e93–e98 PubMedCrossRef

59.

World Health Organisation (2014) Global status report on alcohol and health. World Health Organisation Press, Geneva, Switzerland

60.

Testino G, Patussi V, Scafato E et al (2013) Alcohol, cardiovascular disease and cancer. Alcohol Alcohol 48(5):627–628 PubMedCrossRef

61.

Bergmann MM, Rehm J, Klipstein-Grobusch K et al (2013) The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol 42(6):1772–1790 PubMedCentralPubMedCrossRef

62.

O’Keefe JH, Bhatti SK, Bajwa A et al (2014) Alcohol and cardiovascular health: the dose makes the poison … or the remedy. Mayo Clin Proc 89(3):382–393 CrossRef

63.

Gronroos NN, Alonso A (2010) Diet and risk of atrial fibrillation – epidemiologic and clinical evidence. Circ J 74(10):2029–2038 PubMedCentralPubMedCrossRef

64.

Matsumoto C, Miedema MD, Ofman P et al (2014) An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardiopulm Rehabil Prev 34(3):159–171 PubMedCrossRef

65.

Jaubert MP, Jin Z, Russo C et al (2014) Alcohol consumption and ambulatory blood pressure: a community-based study in an elderly cohort. Am J Hypertens 27(5):688–694 PubMedCentralPubMedCrossRef

66.

Roerecke M, Rehm J (2014) Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart 1(1):e000135 PubMedCentralPubMedCrossRef

67.

Movva R, Figueredo VM (2014) Alcohol and the heart: to abstain or not to abstain? Int J Cardiol 172(3):628 PubMedCrossRef

68.

Holmes MV, Dale CE, Zuccolo L et al (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 349:g4164. doi:10.1136/bmj.g4164 PubMedCentralPubMedCrossRef

69.

Smith GC, Pell JP (2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 327(7429):1459–1461 PubMedCentralPubMedCrossRef

70.

Cornelis MC, El-Sohemy A (2007) Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 18(1):13–19 PubMedCrossRef

71.

Riksen NP, Rongen GA, Smits P (2009) Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther 121(2):185–191 PubMedCrossRef

72.

Renda G, Zimarino M, Antonucci I et al (2012) Genetic determinants of blood pressure responses to caffeine drinking. Am J Clin Nutr 95(1):241–248 PubMedCrossRef

73.

Klatsky AL, Hasan AS, Armstrong MA et al (2011) Coffee, caffeine, and risk of hospitalization for arrhythmias. Perm J 15(3):19–25 PubMedCentralPubMed

74.

Frost L, Vestergaard P (2005) Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 81(3):578–582 PubMed

75.

Conen D, Chiuve SE, Everett BM et al (2010) Caffeine consumption and incident atrial fibrillation in women. Am J Clin Nutr 92(3):509–514 PubMedCentralPubMedCrossRef

76.

Graboys TB, Blatt CM, Lown B (1989) The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia. Arch Intern Med 149(3):637–639 PubMedCrossRef

77.

Pelchovitz DJ, Goldberger JJ (2011) Caffeine and cardiac arrhythmias: a review of the evidence. Am J Med 124(4):284–289 PubMedCrossRef

78.

Caldeira D, Martins C, Alves LB et al (2013) Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart 99(19):1383–1389 PubMedCrossRef

79.

Noordzij M, Uiterwaal CS, Arends LR et al (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23(5):921–928 PubMedCrossRef

80.

Jee SH, He J, Whelton PK et al (1999) The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33(2):647–652 PubMedCrossRef

81.

Giggey PP, Wendell CR, Zonderman AB, Waldstein SR (2011) Greater coffee intake in men is associated with steeper age-related increases in blood pressure. Am J Hypertens 24(3):310–315 PubMedCrossRef

82.

Lane JD, Pieper CF, Phillips-Bute BG et al (2002) Caffeine affects cardiovascular and neuroendocrine activation at work and home. Psychosom Med 64(4):595–603 PubMed

83.

Uiterwaal CS, Verschuren WM, Bueno-de-Mesquita HB et al (2007) Coffee intake and incidence of hypertension. Am J Clin Nutr 85(3):718–723 PubMed

84.

Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC (2005) Habitual caffeine intake and the risk of hypertension in women. JAMA 294(18):2330–2335 PubMedCrossRef

85.

Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E (2011) The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 94(4):1113–1126 PubMedCrossRef

86.

Robertson D, Hollister AS, Kincaid D et al (1984) Caffeine and hypertension. Am J Med 77(1):54–60 PubMedCrossRef

87.

Farag NH, Vincent AS, McKey BS et al (2005) Hemodynamic mechanisms underlying the incomplete tolerance to caffeine’s pressor effects. Am J Cardiol 95(11):1389–1392 PubMedCrossRef

88.

Shechter M, Shalmon G, Scheinowitz M et al (2011) Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease. Am J Cardiol 107(9):1255–1261 PubMedCrossRef

89.

Buscemi S, Verga S, Batsis JA et al (2010) Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr 64(5):483–489 PubMedCrossRef

90.

Freedman ND, Park Y, Abnet CC et al (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366(20):1891–1904 PubMedCentralPubMedCrossRef

91.

Koning Gans JM de, Uiterwaal CS, Schouw YT van der et al (2010) Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol 30(8):1665–1671 CrossRef

92.

Malerba S, Turati F, Galeone C et al (2013) A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 28(7):527–539 PubMedCrossRef

93.

Greenberg JA, Chow G, Ziegelstein RC (2008) Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study). Am J Cardiol 102(11):1502–1508 PubMedCrossRef

94.

Mukamal KJ, Hallqvist J, Hammar N et al (2009) Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J 157(3):495–501 PubMedCrossRef

95.

Larsson SC, Orsini N (2011) Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 174(9):993–1001 PubMedCrossRef

96.

Wu JN, Ho SC, Zhou C et al (2009) Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 137(3):216–225 PubMedCrossRef

97.

Reis JP, Loria CM, Steffen LM et al (2010) Coffee, decaffeinated coffee, caffeine, and tea consumption in young adulthood and atherosclerosis later in life: the CARDIA study. Arterioscler Thromb Vasc Biol 30(10):2059–2066 PubMedCentralPubMedCrossRef

98.

Silletta MG, Marfisi R, Levantesi G et al (2007) Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico)-Prevenzione trial. Circulation 116(25):2944–2951 PubMedCrossRef

99.

Ding M, Bhupathiraju SN, Satija A et al (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 129(6):643–659 PubMedCentralPubMedCrossRef

100.

Mostofsky E, Rice MS, Levitan EB, Mittleman MA (2012) Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail 5(4):401–405 PubMedCentralPubMedCrossRef

101.

Palatini P (2012) Letter by Palatini regarding article, „Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis“. Circ Heart Fail 5(6):e98 PubMedCrossRef

102.

Mostofsky E, Rice MS, Mittleman MA (2012) Response to letter regarding article, „habitual coffee consumption and risk of heart failure: a dose-response meta-analysis“. Circ Heart Fail 5:e99 CrossRef

103.

Grosso G, Stepaniak U, Micek A et al (2014) Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr. doi:10.1007/s00394-014-0789-6

Titel: Schokolade, Alkohol und Kaffee
Lifestyle und kardiovaskuläre Erkrankungen
verfasst von: PD Dr. T. Walter
J. Grüttner
M. Borggrefe
S. Swoboda
Publikationsdatum: 01.06.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Die Kardiologie / Ausgabe 3/2015
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI: https://doi.org/10.1007/s12181-015-0660-x

Neu im Fachgebiet Innere Medizin

27.03.2023 | Hyperaldosteronismus | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Schokolade, Alkohol und Kaffee

Lifestyle und kardiovaskuläre Erkrankungen

Zusammenfassung

Das könnte Sie auch interessieren

Neue Studie zum Krebsrisiko: Abwarten und Tee trinken

Koffein schützt vor Unfällen bei langen Autofahrten

Kein erhöhtes Blasenkrebsrisiko mit Kaffee, Tee und Cola

Genuss von schwarzem Tee lässt den Blutdruck sinken

Neu im Fachgebiet Innere Medizin

Kochsalzreduktion senkt Blutdruck bei Morbus Conn

Schadet Cannabidiol der Leber?

Lokal fortgeschrittenes Magenkarzinom: Laparoskopische und offene Gastrektomie gleichwertig?

Neuer Anlauf fürs Karotisstenting

Update Innere Medizin

Update Innere Medizin

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Bei Typ-2-Diabetes mellitus frühzeitig an Herzinsuffizienz und pAVK denken

Morbus Fabry

Sachkunde „Kardiale Resynchronisationstherapie (CRT)“

Gendiagnostik bei kardiovaskulären Erkrankungen

Eine arteriovenöse Fistel der Beckengefäße senkt den Blutdruck bei Patienten mit therapieresistenter Hypertonie

Neuartiger Stent im Koronarsinus verbessert Lebensqualität bei therapierefraktärer Angina pectoris

Das könnte Sie auch interessieren

Neue Studie zum Krebsrisiko: Abwarten und Tee trinken

Koffein schützt vor Unfällen bei langen Autofahrten

Kein erhöhtes Blasenkrebsrisiko mit Kaffee, Tee und Cola

Genuss von schwarzem Tee lässt den Blutdruck sinken

Neu im Fachgebiet Innere Medizin

Kochsalzreduktion senkt Blutdruck bei Morbus Conn

Schadet Cannabidiol der Leber?

Lokal fortgeschrittenes Magenkarzinom: Laparoskopische und offene Gastrektomie gleichwertig?

Neuer Anlauf fürs Karotisstenting

Update Innere Medizin

Update Innere Medizin